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The patient developed acute renal failure on the second hospital day, and on the third hospital day, he entered a delirious state, with thrombocytopenia, respiratory failure, and severe hypotension. Granulocyte colony stimulating factor (250 lg/day) was administered for his severe pancytopenia on hospital days 4-7. On hospital day 9, his urine output began to increase, and on hospital day 18, the patient had been successfully weaned from the mechanical ventilation. He was discharged from the hospital on hospital day 26. All of the blood and laboratory parameters on hospital day 25 were within the normal ranges, but alopecia, muscle weakness (MMT 4/5), disappeared ankle tendon reflex, reduced evoked potentials of peripheral nerves, including the median, ulnar, and tibial nerves, remained ( Table 1) .
The first symptom of this patient was that of gastrointestinal tract, followed by the subsequent multiple organ failure, including the cardiovascular, renal, hepatic, respiratory, myeloproliferative, central and peripheral nervous systems, which sequentially developed as precisely described in Stapczynski et al.'s review [1] . The severity of our patient's colchicine intoxication correlated well to the intake doses; i.e., an oral intake of \0.5 mg/kg only exerts gastrointestinal tract symptoms, that from 0.5 to 0.8 mg/kg results in multiple organ failure, and an oral intake of [0.8 mg/kg can be lethal [2] . The total intake of colchicine in this patient was 15 mg (0.2 mg/kg), and he did not have any pre-existing diseases. The co-administration of macrolides promotes colchicine's toxicities [3, 4] , but, to our knowledge, there has been only one report of colchicine toxicity in association with indomethacin [5] . Colchicine, anti-inflammatory drugs (NSAIDs), and corticosteroids are commonly used to treat gout. It would appear that a possible interaction between colchicine and NSAIDs could cause a fatal complication.
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